Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Rohatgi

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
European Cardiology|October 13, 2018
Statins: Practical Considerations - A ReviewKazeen Abdullah, Anand Rohatgi
Clinical Lipidology|December 14, 2011
Clinical applications of advanced lipoprotein testing in diabetes mellitusDanyaal S Moin, Anand Rohatgi
Journal of the American College of Cardiology|September 18, 2010
Assessing clinical utility of carotid intima-media thickness on the basis of reclassificationAnand Rohatgi, Jarett D Berry
Current Opinion in Lipidology|September 9, 2022
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future researchJohn T Wilkins, Anand Rohatgi
Methodist Debakey Cardiovascular Journal|May 4, 2019
HDL and Reverse Cholesterol Transport BiomarkersKayla A Riggs, Anand Rohatgi
Journal of the American College of Cardiology|November 14, 2015
Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical ImplicationsAnand Rohatgi, Scott M Grundy
Journal of Clinical Lipidology|August 21, 2022
Is there a connection between HDL and atrial fibrillation?Rachel H Mackey, Anand Rohatgi
Cardiovascular Drugs and Therapy|April 1, 2008
Effects of the thiazolidinedione medications on micro- and macrovascular complications in patients with diabetes--update 2008Anand Rohatgi, Darren K McGuire
Circulation. Cardiovascular Genetics|December 25, 2009
The report card on growth differentiation factor 15: consistent marks but not yet ready for promotionAnand Rohatgi, James A de Lemos
Circulation|May 26, 2010
Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studiesJames A de Lemos, Anand Rohatgi
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
European Cardiology|October 13, 2018
Statins: Practical Considerations - A ReviewKazeen Abdullah, Anand Rohatgi
Clinical Lipidology|December 14, 2011
Clinical applications of advanced lipoprotein testing in diabetes mellitusDanyaal S Moin, Anand Rohatgi
Journal of the American College of Cardiology|September 18, 2010
Assessing clinical utility of carotid intima-media thickness on the basis of reclassificationAnand Rohatgi, Jarett D Berry
Current Opinion in Lipidology|September 9, 2022
Resolution of apolipoprotein A1 and A2 proteoforms: their cardiometabolic correlates and implications for future researchJohn T Wilkins, Anand Rohatgi
Methodist Debakey Cardiovascular Journal|May 4, 2019
HDL and Reverse Cholesterol Transport BiomarkersKayla A Riggs, Anand Rohatgi
Journal of the American College of Cardiology|November 14, 2015
Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical ImplicationsAnand Rohatgi, Scott M Grundy
Journal of Clinical Lipidology|August 21, 2022
Is there a connection between HDL and atrial fibrillation?Rachel H Mackey, Anand Rohatgi
Cardiovascular Drugs and Therapy|April 1, 2008
Effects of the thiazolidinedione medications on micro- and macrovascular complications in patients with diabetes--update 2008Anand Rohatgi, Darren K McGuire
Circulation. Cardiovascular Genetics|December 25, 2009
The report card on growth differentiation factor 15: consistent marks but not yet ready for promotionAnand Rohatgi, James A de Lemos
Circulation|May 26, 2010
Separating the contenders from the pretenders: competitive high-throughput biomarker screening in large population-based studiesJames A de Lemos, Anand Rohatgi
Pageof 13